26 research outputs found
Gene expression and pathway bioinformatics analysis detect a potential predictive value of MAP3K8 in thyroid cancer progression
Thyroid cancer is the commonest endocrine malignancy. Mutation in the BRAF
serine/threonine kinase is the most frequent genetic alteration in thyroid
cancer. Target therapy for advanced and poorly differentiated thyroid
carcinomas include BRAF pathway inhibitors. Here, we evaluated the role of
MAP3K8 expression as a potential driver of resistance to BRAF inhibition in
thyroid cancer. By analyzing Gene Expression Omnibus data repository, across
all thyroid cancer histotypes, we found that MAP3K8 is up-regulated in poorly
differentiated thyroid carcinomas and its expression is related to a stem cell
like phenotype and a poorer prognosis and survival. Taken together these data
unravel a novel mechanism for thyroid cancer progression and chemo-resistance
and confirm previous results obtained in cultured thyroid cancer stem cellsComment: 5 page
Role of FGF System in Neuroendocrine Neoplasms. Potential Therapeutic Applications
Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors originating from neuroendocrine cells dispersed in different organs. Receptor tyrosine kinases are a subclass of tyrosine kinases with a relevant role in several cellular processes including proliferation, differentiation, motility and metabolism. Dysregulation of these receptors is involved in neoplastic development and progression for several tumors, including NENs. In this review, we provide an overview concerning the role of the fibroblast growth factor (FGF)/fibroblast growth factor receptor (FGFR) system in the development and progression of NENs, the occurrence of fibrotic complications and the onset of drug-resistance. Although no specific FGFR kinase inhibitors have been evaluated in NENs, several clinical trials on multitarget tyrosine kinase inhibitors, acting also on FGF system, showed promising anti-tumor activity with an acceptable and manageable safety profile in patients with advanced NENs. Future studies will need to confirm these issues, particularly with the development of new tyrosine kinase inhibitors highly selective for FGFR
CANCRO TIROIDEO E AMBIENTE VULCANICO
Introduzione: L'aumentata incidenza del cancro tiroideo in diverse aree vulcaniche suggerisce una potenziale relazione tra l'ambiente e la contaminazione dei residenti con sostanze chimiche vulcaniche che hanno un effetto cancerogeno sulla tiroide.
Disegno dello studio: abbiamo sviluppato tre fasi: 1) studio epidemiologico: paragone dell incidenza del cancro tiroideo nell area vulcanica dell Etna con quella di un area di controllo non vulcanica.; 2) studio ambientale: paragone delle concentrazioni di metalli pesanti e oligoelementi nelle acque del sistema acquifero dell Etna e dell area di controllo non vulcanica in Sicilia; 3) studio biologico: paragone delle concentrazioni di metalli pesanti e oligoelementi nelle urine dei residenti nell area vulcanica e dell area di controllo in Sicilia.
Metodi: i dati di epidemiologia del cancro tiroideo sono stati estrapolati dal Registro Regionale Siciliano per il Cancro della Tiroide (periodo 2002-2006). In totale, 34 oligoelementi sono stati misurati nelle acque e nelle urine di 278 adulti residenti nell area vulcanica (n = 140 ) e nell area di controllo (n = 138).
Risultati: l'incidenza del cancro tiroideo era superiore nella zona vulcanica (tasso di incidenza standardizzato per l età della popolazione mondiale= 18.5/105 vs 9.6/105 nella zona di controllo). Tale differenza era esclusivamente sostenuta da una maggiore incidenza di cancro tiroideo di istotipo papillare. Nella zona vulcanica i tumori erano più frequentemente multifocali e con estensione extratiroidea (p < 0.01). Gli elementi studiati sono stati trovati ad una concentrazione significativamente maggiore sia nelle acque che nelle urine dei residenti nell area vulcanica, suggerendo la possibilità di una biocontaminazione. In quest area le concentrazioni urinarie di Boro, Molibdeno, Tungsteno e Palladio erano superiori ai valori di riferimento per l Italia in oltre il 20% dei campioni analizzati.
Conclusioni: nell area vulcanica dell Etna, caratterizzata da un elevata incidenza di cancro tiroideo, le concentrazioni di diversi oligoelementi e metalli pesanti sono significativamente aumentate nelle acque e nelle urine dei residenti. Questa associazione è compatibile (ma non dimostra) con una relazione di causa - effetto tra una o più di queste sostanze chimiche di origine vulcanica e il cancro tiroideo
The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms
Peptide receptor radionuclide therapy (PRRT), also called radioligand therapy, is an effective antitumoral treatment in patients with neuroendocrine neoplasm (NEN). It improves the patient’s health-related quality of life (HRQoL), which is evaluated by self-assessment questionnaires. The aim of this narrative review was to report the current knowledge on the changes of HRQoL and sexual function in patients with NEN treated with PRRT. We conducted a literature search of the PubMed, Embase, and APA PsycInfo databases. We selected 15 studies (12 for HRQoL and three for sexual function). After treatment with PRRT, patients with NEN experienced a significant improvement in their global health status, disease-related worries, social and emotional functioning, and cancer-related symptoms such as fatigue and diarrhea. Other symptoms, such as nausea/vomiting, dyspnea, and constipation, as well as the economic impact, were unchanged by radioligand therapy. Data on sexual function were not equally promising; only a few studies investigated this issue by using appropriate questionnaires in patients treated with radioligand therapy. Therefore, additional studies are needed to draw a conclusion about the benefits from PRRT on sexual function
Perchlorates in the treatment of hyperthyroidism and thyrotoxicosis: a comprehensive review
IntroductionPerchlorates are ionic inhibitors antagonizing iodine transport into thyrocytes, hampering thyroid hormone synthesis. Nevertheless, perchlorates are not considered as first-line treatment in hyperthyroidism and thyrotoxicosis as compared to other pharmacological and non-pharmacological interventions.AimReassessing the therapeutic role of perchlorates in hyperthyroidism and thyrotoxicosis throughout a systematic review of the Literature.MethodsGuidelines were searched and examined to summarize current recommendations on the use of perchlorates in the management of hyperthyroidism. Randomized and non-randomized clinical trials were also searched and reviewed to summarize the efficacy/effectiveness and safety of perchlorates in hyperthyroidisms and thyrotoxicosis.ResultsThe management of specific forms of hyperthyroidism was considered, including Graves' disease (GD) in non-pregnant adults, hyperthyroidisms in pregnancy, iodine media contrast-induced hyperthyroidism, amiodarone-induced hyperthyroidisms, and thyroid storm. Most of the reported studies had remarkable limitations in terms of study design (non-controlled trials, lack of blinding), low number of participants, and the lack of clinically relevant endpoints, such as cardiovascular events, cardiovascular mortality, and teratogenicity. Overall, perchlorates could be considered a second-line treatment after thionamides, radioiodine, and total thyroidectomy in both GD and hyperthyroidisms in pregnancy. The therapeutic potential of perchlorates alone or in combination with other agents could be considered a second-line treatment of iodine-related hyperthyroidisms and thyroid storm.ConclusionDespite the low level of evidence, perchlorates could be considered in such specific forms of thyroid disorders, including iodine-induced hyperthyroidism and thyroid storm
The Possible Role of Cancer Stem Cells in the Resistance to Kinase Inhibitors of Advanced Thyroid Cancer
Predictive factors of response to mTOR inhibitors in neuroendocrine tumours.
Medical treatment of neuroendocrine tumours (NETs) has drawn a lot of attention due to the recent demonstration of efficacy of several drugs on progression-free survival, including somatostatin analogs, small tyrosine kinase inhibitors and mTOR inhibitors (or rapalogs). The
latter are approved as therapeutic agents in advanced pancreatic NETs and have been demonstrated to be effective in different types of NETs, with variable efficacy due to the development of resistance to treatment. Early detection of patients that may benefit from rapalogs treatment is of paramount importance in order to select the better treatment and avoid ineffective and expensive treatments. Predictive markers for herapeutic response are under intensive investigation, aiming at a tailored patient management and more appropriate resource utilization. This review summarizes the available data on the tissue, circulating and imaging markers that are potentially predictive of rapalog efficacy in NETs
Increased Thyroid Cancer Incidence in Volcanic Areas: A Role of Increased Heavy Metals in the Environment?
Thyroid cancer incidence is significantly increased in volcanic areas, where relevant non-anthropogenic pollution with heavy metals is present in the environment. This review will discuss whether chronic lifelong exposure to slightly increased levels of metals can contribute to the increase in thyroid cancer in the residents of a volcanic area. The influence of metals on living cells depends on the physicochemical properties of the metals and their interaction with the target cell metallostasis network, which includes transporters, intracellular binding proteins, and metal-responsive elements. Very little is known about the carcinogenic potential of slightly increased metal levels on the thyroid, which might be more sensitive to mutagenic damage because of its unique biology related to iodine, which is a very reactive and strongly oxidizing agent. Different mechanisms could explain the specific carcinogenic effect of borderline/high environmental levels of metals on the thyroid, including (a) hormesis, the nonlinear response to chemicals causing important biological effects at low concentrations; (b) metal accumulation in the thyroid relative to other tissues; and (c) the specific effects of a mixture of different metals. Recent evidence related to all of these mechanisms is now available, and the data are compatible with a cause–effect relationship between increased metal levels in the environment and an increase in thyroid cancer incidence
Prognostic Effect of Lymph Node Metastases and Mesenteric Deposits in Neuroendocrine Tumors of the Small Bowel
Well-differentiated, low-grade neuroendocrine tumors (NETs) are the most frequent tumor types of the small bowel. Despite their generally indolent growth patterns and grade, these tumors tend to metastasize; indeed, at presentation, approximately 50% show nodal metastases and 30% of patients have distant metastases, even though they potentially show long survival. Little is available in the literature concerning the optimal nodal yield in small-bowel resections, and the clinical significance of nodal metastases and lymph node ratio (LNR) at this site is still debated. The aim of this review, through a systematic literature search, is to explore and analyze data regarding nodal status, adequacy of lymphadenectomy, and LNR on the prognosis of small bowel NETs using defined end points (progression-free survival, recurrence-free survival, and overall survival). Some surgical series have demonstrated that extended regional mesenteric lymphadenectomy, together with primary tumor resection, is associated with improved patient survival, and LNR is proving a prognostically important parameter. The new feature of mesenteric tumor deposits (MTDs; neoplastic deposits found in the mesenteric perivisceral adipose tissue that are not LN associated) seems to be a better prognostic predictor in small-bowel NETs compared to nodal metastases, and this feature is explored and critiqued in this review. In particular, increasing number of tumor deposits is correlated with increased risk of disease-specific death, and MTDs seem to correlate with peritoneal carcinomatosis